Tildrakizumab is an interleukin-23 antagonist approved under the brand name Ilumya for the treatment of plaque psoriasis.

Understand how psoriatic arthritis increases heart disease risk through inflammation. Learn management tips for heart health, from lifestyle changes to medication discussions.

Dupilumab use for atopic dermatitis and other conditions was associated with an increased risk of incident psoriasis but not psoriatic arthritis.

These four Dividend Aristocrats are Buy-rated sector leaders with yields above 3%. Passive income investors can buy and hold ...

What’s behind the rise in maternal mental health struggles? And more importantly, what can be done to help mothers dealing ...

Contrary to what salon ads may suggest, “Scalp Botox” refers to the injection of Botulinum toxin (commonly called Botox) into ...